|
Match
|
Document |
Document Title |
|
|
US20110123517 |
DISSOLVABLE PHARMACEUTICAL IMPLANT
A pharmaceutical implant may include a pharmaceutical and at least one excipient, and may be configured to be implanted in a body of a patient. The at least one excipient may dissolve after...
|
|
|
US20110021439 |
USE OF TRANSESTERIFIED OLIVE OIL IN THE COSMETIC FIELD
The use of transesterified olive oil for increasing the penetration rate of cosmetically-active and/or dermatologically-active ingredients or as cosmetic moisturiser is disclosed.
|
|
|
US20110097367 |
MONOLITHIC IN-SITU CROSS-LINKED ALGINATE IMPLANTS
A method of making and using a monolithic alginate implant is described. The implant is formed by providing an uncrosslinked, highly pure and high molecular weight alginate solution and injecting...
|
|
|
US20120065160 |
DELIVERY SYSTEM FOR DELIVERY OF A SUBSTANCE INTO THE ORAL CAVITY
A delivery system for use in the oral cavity, the system comprising a carrier for a bioactive substance. The carrier has a surface comprising oxygen-binding sites (X), and at least one link...
|
|
|
US20110206754 |
IMPLANT DEVICE
The present description relates to an implant device, having an improved integration in the tissue of the animal or human body into which it is inserted, when compared to the prior art devices....
|
|
|
US20110311442 |
DIRECT CELLULAR ENERGY DELIVERY SYSTEM
A lipid vesicle comprising a phospholipid which is a stable vesicle former and at least one unstable vesicle forming member, wherein the unstable vesicle forming member is selected from the group...
|
|
|
US20120116215 |
DEPLOYMENT OF POLYSACCHARIDE MARKERS FOR TREATING A SITE WITHIN A PATIENT
A method for treating a site within a patient from which tissue has been removed includes providing at least one press-formed marker body formed of polysaccharide and a suitable binder; and placing...
|
|
|
US20110129801 |
COMPOSITIONS AND METHODS TO PREVENT AND TREAT DRY SOCKET POST-OPERATIVELY AFTER TOOTH EXTRACTION SURGERY
The invention describes and claims compositions and methods for their use in the prevention and treatment of alveolar osteitis (dry socket) after tooth extraction surgery.
|
|
|
US20110286998 |
METHODS FOR TREATING AND PREVENTING CANCERS THAT EXPRESS THE HYPOTHALAMIC-PITUITARY-GONADAL AXIS OF HORMONES AND RECEPTORS
Methods are provided for treating HPG axis-positive cancers, preventing or slowing proliferation of cells of HPG axis-positive cancer origin, preventing HPG axis-positive cancers in a patient at...
|
|
|
US20110150976 |
TRANSDERMAL DELIVERY OF OLIGOSACCHARIDES
The present invention relates to a system for facilitating transdermal delivery of oligosaccharides, The system includes an apparatus that generates micro-channels in the skin of a subject and a...
|
|
|
US20110300227 |
MALIGNANT NEOPLASM TREATMENT PROTOCOL
Methods, compositions, and strategies for the treatment of malignant neoplasms are presented herein. The treatment modalities are directed towards exploiting characteristics of cancer cells as well...
|
|
|
US20120040926 |
Process For Obtaining Polysaccharides From Jatoba (Hymenea Courbaril L) Seeds, Cosmetic Composition Comprising Said Polysaccharides And Uses Thereof
The present invention relates to a process for obtaining polysaccharides from jatoba seeds, comprising the steps of: a) seed processing (dry process); b) aqueous extraction at 1% to 5% of powder...
|
|
|
US20120035129 |
HYDROGEL TISSUE ADHESIVE HAVING REDUCED DEGRADATION TIME
A hydrogel tissue adhesive having decreased degradation time is described. The hydrogel tissue adhesive is formed by reacting an oxidized polysaccharide with a water-dispersible, multi-arm...
|
|
|
US20110213020 |
IMMUNOSTIMULANT COMPOSITIONS COMPRISING A NUCLEOBASE AND A POLYSACCHARIDE OBTAINABLE FROM FUNGI, YEAST OR BACTERIA
The present invention relates to compositions comprising nucleobases and/or sources of nucleobases and polysaccharides from extracts of fungi, yeasts or bacteria. Preferably, the compositions...
|
|
|
US20110124595 |
METHOD FOR PREPARING POLYSACCHARIDE OF GREEN TEA AND COSMETIC COMPOSITION FOR SKIN WHITENING, MOISTURIZATION AND ANTI-WRINKLE EFFECTS COMPRISING THE POLYSACCHARIDE
Disclosed is a method for preparing polysaccharides of green tea, and more particularly to a method for preparing polysaccharides of green tea comprising the steps of: a) removing chlorophyll and a...
|
|
|
US20110047631 |
HEAT SHOCK PROTEIN DEFICIENCIES AS MODEL SYSTEMS FOR BRAIN PATHOLOGY AND CANCER
The invention provides non-human transgenic animals as models of neurodegenerative brain pathology, including, but not limited to, Alzheimer's disease (AD), and cancer. The non-human transgenic...
|
|
|
US20110172181 |
Compositions and Methods of Aloe Polysaccharides
The present invention describes a method for preparing a polymannan extract from freeze-dried aloe powder. The polymannan extract of the present invention is further used to formulate a sterile...
|
|
|
US20100331710 |
BLOOD PRESSURE MEASUREMENT CUFF THAT INCLUDES AN ANTIMICROBIAL SUBSTANCE
A blood pressure measurement cuff comprising an inflatable bladder, a source of fluidic pressure in fluidic communication with the inflatable bladder, a manometer in fluidic communication with the...
|
|
|
US20120122768 |
ALGINATE OLIGOMERS FOR USE IN OVERCOMING MULTIDRUG RESISTANCE IN BACTERIA
The invention provides a method of overcoming resistance to at least one antibiotic in a multidrug resistant bacterium, said method comprising contacting said bacterium with an alginate oligomer...
|
|
|
US20110224165 |
FORMULATIONS AND METHODS FOR REDUCING WAIST CIRCUMFERENCE
Methods for reducing abdominal fat and waist circumference in a human subject are disclosed. The method includes a composition containing Lycium plant that, when administered to a human, can reduce...
|
|
|
US20100092420 |
Preservative Systems Comprising Cationic Surfactants
Preservative systems on the basis of cationic surfactants are known i n the art, a typical example of such cationic surfactants is the ethyl ester of the lauramide of arginine monohydrochloride...
|
|
|
US20110195061 |
COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING A MIXTURE OF FISH OIL AND FISH OIL DERIVED, CHOLINE BASED, PHOSPHOLIPID BOUND FATTY ACID MIXTURE INCLUDING POLYUNSATURATED EPA AND DHA
Beneficial and synergistic effects for alleviating joint pain and symptoms of osteoarthritis and/or rheumatoid arthritis have been found using a mixture of fish oil and fish oil derived, choline...
|
|
|
US20110091506 |
VACCINE COMPOSITIONS
The present invention provides methods for the treatment or prevention of allergic airways diseases, the suppression of allergic immune responses, and the induction protective immunity against...
|
|
|
US20100298628 |
STRESS URINARY INCONTINENCE TREATMENT
A method for stabilizing a urethra in a female patient having stress urinary incontinence caused by stretching of a pubourethral ligament includes filling a substantial portion of the pubourethral...
|
|
|
US20120027817 |
Absorbable Implants and Methods for Their Use in Hemostasis
The present invention relates to mechanically hemostatic body-absorbable compositions having a putty-like consistency comprising a finely powdered polysaccharide and a biocompatible liquid...
|
|
|
US20120107414 |
PHARMACEUTICAL FORMULATIONS AND METHODS FOR TREATING RESPIRATORY TRACT INFECTIONS
The present invention relates to pharmaceutical formulations for treating a respiratory tract infection or a pulmonary disease in an individual, comprising a calcium salt and a sodium salt, wherein...
|
|
|
US20120058969 |
Cystitis treatment with high dose chondroitin sulfate
Interstitial cystitis and related GAG-deficient conditions of the bladder and urinary tract are treated by instillation of high dose chondroitin sulfate, such as 400 mg/20 mL. The higher dose of...
|
|
|
US20110008476 |
Methods of Treating or Preventing Inflammatory Diseases of the Intestinal Tract
The present invention relates to a glucan derived from yeast having a beta-(1, 3)-backbone with one or more beta-(1, 3)-side chains linked thereto for use in the treatment or prevention of...
|
|
|
US20100323958 |
Methods of Use of Biomaterial and Injectable Implant Containing Biomaterial
This invention relates to the use of a biomaterial for the treatment, repair and/or enhancement of bodily tissue insufficiencies of the vocal chords, muscles, ligaments, cartilage, post-operative...
|
|
|
US20120094950 |
Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis
The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.
|
|
|
US20110009360 |
Nutraceutical Composition and Methods for Preventing or Treating Multiple Sclerosis
The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.
|
|
|
US20100311686 |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
The present invention embraces nutraceutical compositions containing isolated Bacteroides fragilis capsular polysaccharide A for use in methods of preventing or treating multiple sclerosis.
|
|
|
US20120100231 |
Antimicrobial Compositions And Methods Of Making And Using The Same
Antimicrobial (e.g., moldicide, fungicide, bacteriacide, and virucide) compositions are disclosed. Methods of making and using antimicrobial (e.g., moldicide, fungicide, bacteriacide, and virucide)...
|
|
|
US20100323043 |
Antimicrobial Compositions and Methods of Making and Using the Same
Antimicrobial (e.g., moldicide, fungicide, and bacteriacide) compositions are disclosed. Methods of making and using antimicrobial (e.g., moldicide, fungicide, and bacteriacide) compositions are...
|
|
|
US20110224167 |
Skin-Protecting Alkalinity-Controlling Composition and the Use Thereof
A skin-protecting alkalinity-controlling composition comprises one or more carboxylic acid polysaccharides. Said compositions are capable of providing buffering, and thus avoiding a major increase...
|
|
|
US20110250259 |
Method of treating and preventing breast diseases and breast cancer with medicated formula
Breast cancer is a common cancer in women. Early diagnosis and treatments are vital for better outcomes. This formula consists of a liquid anti-disease anti-cancer formula that can be delivered to...
|
|
|
US20080227748 |
Medicament Made From Laminarine or Oligolaminarines For Treatment of Septicemia and Septic Shock
The invention relates Lo the use of laminarine, preferably in the soluble form thereof or an oligolaminarine, for the production of a medicament for treatment of septicemia and septic shock.
|
|
|
US20110311610 |
TEMPERATURE REDUCING, HEALING WOUND DRESSING
The present invention relates to wound dressings having a wound contacting layer that contains a wound healing composition and which is adapted to maintain a temperature different from ambient, for...
|
|
|
US20110207659 |
OLIGOSACCHARIDE COMPOSITIONS AND USE THEREOF IN THE TREATMENT OF INFECTION
Oligosaccharides and oligosaccharides linked to backbones such as proteins, methods for making such oligosaccharides and methods for using them to treat and/or prevent various disorders are described.
|
|
|
US20110224724 |
HYDROGEL TISSUE ADHESIVE FORMED FROM AMINATED POLYSACCHARIDE AND ALDEHYDE-FUNCTIONALIZED MULTI-ARM POLYETHER
A hydrogel tissue adhesive formed by reacting an aminated polysaccharide with a water-dispersible, aldehyde-functionalized multi-arm polyether is described. The hydrogel tissue adhesive may be...
|
|
|
US20120115803 |
TREATMENT OF ACINETOBACTER WITH ALGINATE OLIGOMERS AND ANTIBIOTICS
The invention provides a method to improve the efficacy of an antibiotic to inhibit the growth of Acinetobacter, said method comprising using said antibiotic together with an alginate oligomer. The...
|
|
|
US20110212914 |
STABILIZED PENTOSAN POLYSULFATE (PPS) FORMULATIONS AND METHODS OF ANALYZING THEM
Various pentosan polysulfate (PPS) formulations useful for treatment of osteoarthritis, interstitial cystitis, and other conditions of mammals are provided. These formulations showed improved...
|
|
|
US20110229446 |
Method and composition to relieve sexual discomfort and improve vaginal health
A method to reduce sexual discomfort for a woman during sexual intercourse vaginally introduces a lubricant composition comprising carrageenan comprising 0 to 92% by weight iota carrageenan, 10% to...
|
|
|
US20120078229 |
IN VIVO BIOREACTORS AND METHODS OF MAKING AND USING SAME
The present invention relates to an in vivo method of promoting the growth of autologous cartilage and bone tissue, including tissue that can be explanted to other locations in the subject.
|
|
|
US20100330211 |
FUCOIDAN COMPOSITIONS AND METHODS FOR DIETARY AND NUTRITIONAL SUPPLEMENTS
Compositions and methods relating to partially hydrolyzed fucoidan for use in dietary supplements are described. Fucoidan from brown seaweeds is partially hydrolyzed and then mixed with other...
|
|
|
US20110177021 |
COMPOSITION FOR FORMING A TEMPORARY OBSTRUCTION AND METHOD OF FORMING THE SAME
The present invention relates to a method for forming a temporary obstruction of the intestine of a mammal, using a solidifiable composition, said composition being flow-able and solidifiable to...
|
|
|
US20110081401 |
DERMAL PATCH COMPRISING CHONDRUS CRISPUS EXTRACT
The present invention relates to masks for dermal treatment or “patches”, based on a vegetal matrix, particularly red algae (Chondrus crispus) extract rich in polymeric thickeners. The inv...
|
|
|
US20110111011 |
SUBLINGUAL APOMORPHINE
The invention features sublingual formulations of apomorphine and apomorphine prodrugs, and methods of treating Parkinson's disease, sexual dysfunction, and depressive disorders therewith.
|
|
|
US20110126767 |
METHODS AND COMPOSITIONS FOR INCREASING THE HATCHABILITY OF HATCHERY EGGS
The invention relates to a method for hatching of hatchery eggs comprising: (a) treating the egg shell surface with a coating composition comprising a coating agent, to form a coating on the...
|
|
|
US20090298745 |
Treatment of Diabetes with Glycogen Phosphorylase Inhibitors
The invention provides a method of treatment of diabetes, particularly type II diabetes, or a diabetes related condition, comprising night time dosing of an inhibitor of glycogen phosphorylase,...
|